Menu
The grades of four pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
Mylan's (MYL) break from a triangle was followed by a strong buy signal on high volume. More
This week, four pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Healthcare stocks remained flat so far on Thursday on Wall Street. More
Healthcare stocks remained flat so far on Tuesday on Wall Street. More
Healthcare stocks rose broadly on Wall Street so far on Monday, with the sector seeing an overall increase of 0.2%. More
Mylan just announced a deal to buy Abbott Labs' global generics business. MYL stock is popping now, but should run for some time thanks to the big tailwind that generic drug stocks are getting right now. More
